FAIRMOUNT FUNDS MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
FAIRMOUNT FUNDS MANAGEMENT LLC portfolio value:
$30.05M
portfolio value
FAIRMOUNT FUNDS MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.47M | $106.21 | 283K | |
| Q2 2022 | share | Increase | 0.00% | 283K shares | 27.58M | $97.48 | 283K |